1.591
price down icon1.36%   -0.022
 
loading
前日終値:
$1.613
開ける:
$1.59
24時間の取引高:
67,524
Relative Volume:
0.21
時価総額:
$161.77M
収益:
$5.15M
当期純損益:
$-65.35M
株価収益率:
-1.1785
EPS:
-1.35
ネットキャッシュフロー:
$-20.85M
1週間 パフォーマンス:
+3.99%
1か月 パフォーマンス:
+26.27%
6か月 パフォーマンス:
-11.61%
1年 パフォーマンス:
-46.79%
1日の値動き範囲:
Value
$1.58
$1.65
1週間の範囲:
Value
$1.4908
$1.65
52週間の値動き範囲:
Value
$1.10
$3.38

Cellectis Adr Stock (CLLS) Company Profile

Name
名前
Cellectis Adr
Name
セクター
Healthcare (1152)
Name
電話
-
Name
住所
-
Name
職員
222
Name
Twitter
@cellectis
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
CLLS's Discussions on Twitter

CLLS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CLLS
Cellectis Adr
1.591 161.77M 5.15M -65.35M -20.85M -1.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.15 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.61 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
649.67 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.39 32.56B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
255.77 26.40B 3.81B -644.79M -669.77M -6.24

Cellectis Adr Stock (CLLS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-03-17 開始されました Bryan Garnier Buy
2022-05-18 アップグレード Robert W. Baird Neutral → Outperform
2022-01-06 ダウングレード Wells Fargo Overweight → Equal Weight
2021-11-30 開始されました JMP Securities Mkt Outperform
2021-11-08 ダウングレード William Blair Outperform → Mkt Perform
2021-10-08 ダウングレード Robert W. Baird Outperform → Neutral
2021-04-28 ダウングレード Guggenheim Buy → Neutral
2021-03-16 アップグレード Robert W. Baird Neutral → Outperform
2020-08-19 アップグレード Citigroup Neutral → Buy
2020-05-12 開始されました Robert W. Baird Outperform
2020-03-06 ダウングレード Goldman Neutral → Sell
2019-10-30 再開されました Guggenheim Buy
2019-08-09 開始されました BTIG Research Buy
2019-05-24 再開されました Citigroup Neutral
2019-03-14 開始されました William Blair Outperform
2018-12-19 開始されました Goldman Neutral
2018-07-16 開始されました Barclays Overweight
2018-03-16 開始されました Guggenheim Neutral
2017-09-05 ダウングレード SunTrust Buy → Hold
2017-09-05 繰り返されました Wells Fargo Outperform
2017-03-02 開始されました Instinet Buy
2017-02-28 開始されました Wells Fargo Outperform
2016-04-05 開始されました Ladenburg Thalmann Buy
2016-03-02 開始されました Sun Trust Rbsn Humphrey Buy
2015-07-20 開始されました BofA/Merrill Buy
2015-04-20 開始されました Jefferies Buy
2015-04-20 開始されました Piper Jaffray Overweight
すべてを表示

Cellectis Adr (CLLS) 最新ニュース

pulisher
Apr 22, 2025

Cellectis Charts Course For 2025 With Boost From AstraZeneca Deal - Barchart.com

Apr 22, 2025
pulisher
Apr 11, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - TradingView

Apr 11, 2025
pulisher
Apr 08, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView

Apr 08, 2025
pulisher
Apr 04, 2025

Cellectis stock touches 52-week low at $1.14 amid market challenges - Investing.com

Apr 04, 2025
pulisher
Apr 02, 2025

European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - TradingView

Apr 02, 2025
pulisher
Mar 20, 2025

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading - TradingView

Mar 20, 2025
pulisher
Mar 18, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView

Mar 18, 2025
pulisher
Mar 17, 2025

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Cellectis’s SWOT analysis: biotech firm’s stock faces CAR T challenges - Investing.com

Mar 17, 2025
pulisher
Mar 15, 2025

Earnings call transcript: Cellectis beats Q4 2024 expectations, stock up 10% By Investing.com - Investing.com South Africa

Mar 15, 2025
pulisher
Mar 14, 2025

Cellectis stock touches 52-week low at $1.2 amid market challenges - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

Earnings call transcript: Cellectis beats Q4 2024 expectations, stock up 10% - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

What Recent Market Trends Mean for Cosan S.A ADR’s (CSAN) Stock - The News Heater

Mar 14, 2025
pulisher
Mar 11, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView

Mar 11, 2025
pulisher
Mar 07, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week - TradingView

Mar 07, 2025
pulisher
Mar 06, 2025

Cellectis stock touches 52-week low at $1.24 amid market challenges - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading - TradingView

Mar 06, 2025
pulisher
Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025
pulisher
Feb 27, 2025

StockNews.com Begins Coverage on Cellectis (NASDAQ:CLLS) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Cellectis earnings missed by $0.20, revenue fell short of estimates - Investing.com

Feb 27, 2025
pulisher
Feb 25, 2025

Cellectis stock touches 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Cellectis stock touches 52-week low at $1.4 amid market challenges - Investing.com India

Feb 25, 2025
pulisher
Feb 24, 2025

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025 - GlobeNewswire Inc.

Feb 24, 2025
pulisher
Feb 14, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Up 1% for Week - TradingView

Feb 14, 2025
pulisher
Feb 07, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, End Week Up 3.2% - TradingView

Feb 07, 2025
pulisher
Jan 03, 2025

This Penny Stock Has 270% Upside Potential In 2025. Is It A Buy Now? - Barchart

Jan 03, 2025
pulisher
Dec 29, 2024

Analysts Predict 400% Upside Potential for This Penny Stock - Yahoo Finance

Dec 29, 2024
pulisher
Dec 26, 2024

Cellectis stock plunges to 52-week low at $1.52 amid market challenges - Investing.com India

Dec 26, 2024
pulisher
Dec 16, 2024

Cellectis stock touches 52-week low at $1.7 amid market challenges - Investing.com

Dec 16, 2024
pulisher
Dec 15, 2024

Cellectis's SWOT analysis: CAR T pioneer's stock faces pivotal year - Investing.com India

Dec 15, 2024
pulisher
Nov 25, 2024

Cellectis's SWOT analysis: CAR T pioneer's stock faces pivotal year ahead - Investing.com

Nov 25, 2024
pulisher
Nov 20, 2024

European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN

Nov 20, 2024
pulisher
Nov 12, 2024

Cellectis's SWOT analysis: gene-editing firm's stock faces pivotal year ahead - Investing.com

Nov 12, 2024
pulisher
Nov 06, 2024

Cellectis stock touches 52-week low at $1.75 amid market challenges - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Earnings call: Cellectis reports robust cash reserves, new R&D initiatives - Investing.com

Nov 06, 2024
pulisher
Nov 05, 2024

Baird maintains $10 target on Cellectis amid strong AZN partnership - Investing.com

Nov 05, 2024
pulisher
Nov 04, 2024

Cellectis earnings missed by $0.03, revenue topped estimates By Investing.com - Investing.com South Africa

Nov 04, 2024
pulisher
Nov 04, 2024

Cellectis earnings missed by $0.03, revenue topped estimates - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Cellectis Provides Business Updates and Financial Results for Third Quarter 2024 - Yahoo Finance

Nov 04, 2024
pulisher
Oct 30, 2024

Cellectis stock touches 52-week low at $1.77 amid market shifts By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Cellectis stock touches 52-week low at $1.77 amid market shifts - Investing.com

Oct 30, 2024
pulisher
Oct 23, 2024

European Equities Traded in the US as American Depositary Receipts Nudge Lower in Tuesday Trading - MSN

Oct 23, 2024
pulisher
May 06, 2024

AstraZeneca completes equity investment agreement with Cellectis - AstraZeneca

May 06, 2024
pulisher
Nov 01, 2023

AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions - AstraZeneca

Nov 01, 2023
pulisher
Aug 01, 2023

CellectisADR (CLLS) Price Target Increased by 7.35% to 11.62 - Nasdaq

Aug 01, 2023
pulisher
Jun 30, 2022

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing - Nature

Jun 30, 2022
pulisher
Feb 26, 2021

Biotech Stocks Rise After FDA Halts Test By Rival Blood Cancer Firm Cellectis - Investor's Business Daily

Feb 26, 2021
pulisher
Feb 21, 2021

Current Cathie Wood Portfolio 2021: Ark Invest Holdings - New Trader U

Feb 21, 2021
pulisher
Dec 28, 2020

Current Cathie Wood Portfolio 2020: Ark Invest Holdings - New Trader U

Dec 28, 2020
pulisher
Oct 18, 2017

7 Gene Editing Companies Investors Should Watch - Nanalyze

Oct 18, 2017
pulisher
Jul 21, 2017

AZN Stock Price and Chart — LSE:AZN - TradingView

Jul 21, 2017

Cellectis Adr (CLLS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$72.30
price down icon 0.47%
$21.48
price up icon 2.63%
$32.89
price up icon 1.26%
$27.90
price up icon 13.09%
$104.94
price up icon 2.45%
biotechnology ONC
$255.77
price up icon 0.05%
大文字化:     |  ボリューム (24 時間):